Bigtincan joins list of junior ASX tech companies adapting to COVID-19

The Bigtincan Holdings Ltd (ASX: BTH) share price rallied recently after the company reported strong growth in recurring revenues

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bigtincan Holdings Ltd (ASX: BTH) share price has climbed steadily after the ASX software company reported a big jump in annualised recurring revenues over the June quarter.

Since crashing in mid-March to a 52-week low of just $0.265, the Bigtincan share price has surged more than 230% to $0.89 in mid-morning trade today.

What does the company do?

Bigtincan develops software to streamline and automate sales and marketing functions for its business clients.

Bigtincan's flagship sales enablement automation platform is a centralised, integrated software solution designed to support businesses throughout their entire sales and marketing lifecycle. That's from onboarding and training new staff, to engaging new customers and providing accurate reporting.

How is Bigtincan performing?

Despite the challenges of operating during COVID-19, results for the June quarter were strong across just about all key financial metrics. Quarterly customer cash receipts were up 89% against the prior comparative period to $10.4 million, while annualised recurring revenues were up 53% year-on-year to $35.8 million. The company reiterated its FY20 guidance for organic revenue growth of between 30% and 40%.

The software company's balance sheet was also healthy with $71.9 million in cash and equivalents as at June 30. This had been strengthened by an oversubscribed $35 million institutional placement and $7.5 million share purchase plan, both of which occurred within the June quarter.

Bigtincan says it will use these funds to invest in its technology and pursue potential M&A opportunities, which means some exciting announcements could be on the horizon.

Should you invest?

Bigtincan isn't quite the same growth company it was last year. In 2019, the Bigtincan share price soared more than 160%. So far this year – after all the share market volatility stemming from COVID-19 – its share price has only managed to gain 29%. This is still well short of its January high of $1.08.

However, the company's underlying results have remained strong, and it has built a solid foundation for future growth despite tough market conditions. It anticipates customer retention rates to remain stable during FY20, and even reported some significant new customer wins in the most recent quarter – including one of the largest technology companies in the world.

There is even the potential for the ongoing impacts from COVID-19 to continue to drive growth. With people continuing to work remotely, there could be sustained high demand for digital solutions for activities such as staff training, coaching and ongoing development.

There are obvious risks to an investment as well. Bigtincan is still a small company with a market cap of only $335 million. With most economic indicators pointing to a severe downturn lurking on the horizon, small-cap growth stocks aren't quite the exciting investment opportunity they were 12 to 18 months ago.

However, Bigtincan joins a growing list of junior ASX tech companies, like internet communications company MNF Group Ltd (ASX: MNF) and software developer Objective Corporation Limited (ASX: OCL), that are showing their ability to adapt – and even thrive – in the challenging conditions created out of the COVID-19 global pandemic.

Rhys Brock has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Objective Limited. The Motley Fool Australia owns shares of and has recommended MNF Group Limited. The Motley Fool Australia has recommended BIGTINCAN FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »